The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: Effect of thrombomodulin

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 5, 1998, Pages 419-427

  Braat, E A M ^a   Los, P ^a   Rijken, D C ^a  

^a TNO   (Netherlands)

Author keywords

Fibrinolysis; Inhibition; Protein C; Thrombin; Thrombomodulin; Urokinase

Indexed keywords

PROTEIN C; THROMBIN; THROMBOMODULIN; UROKINASE;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; COMPLEX FORMATION; DISULFIDE BOND; DRUG EFFECT; ENZYME INACTIVATION; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN DEGRADATION;

EID: 0031846963     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199807000-00004     Document Type: Article

References (38)

1. Emeis JJ, Verheijen JH, Ronday HK, De Maat MPM, Brakman P. Progress in clinical fibrinolysis. Fibrinol Proteol 1997; 11: 67-84.
2. Eaton DL, Scott RW, Baker JB. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem 1984; 259: 6241-6247.
3. Kasai S, Arimura H, Nishida M, Suyama T. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. J Biol Chem 1985; 260: 12377-12381.
4. Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986; 261: 3486-3489.
5. Marcotte PA, Henkin J. Characterization of the activation of pro-urokinase by thermolysin. Biochim Biophys Acta 1993; 1160: 105-112.
6. Stack MS, Johnson DA. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 1994; 269: 9416-9419.
7. Schmitt M, Jänicke F, Graeff H. Tumor-associated proteases. Fibrinolysis 1992; 6 (suppl 4): 3-26.
8. Liu J, Gurewich V. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. Blood 1993; 81: 980-987.
9. Collen D, Dewerchin M, Stassen JM, Kieckens L, Lijnen HR. Thrombolytic and pharmacokinetic properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for crosslinked fibrin. Fibrinolysis 1989; 3: 197-202.
10. Abercrombie DM, Buchinski B, Salvato KA, Vovis GF, Stump DC, Broeze RJ. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin. Thromb Haemost 1990; 64: 426-432.
11. Braat EAM, Nauland U, Dooijewaard G, Rijken DC. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids. Thromb Haemost 1996; 75: 908-914.
12. Gurewich V, Pannell R. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments. Blood 1987; 69: 769-772.
13. Rijken DC, De Munk GAW, Nauland U. Inactivation of single-chain urokinase-type plasminogen activator (pro-urokinase) by thrombin. Biol Clin Hematol 1993; 15: 127-131.
14. De Munk GAW, Groeneveld E, Rijken DC. Acceleration of the thrombin inactivation of single-chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin. J Clin Invest 1991; 88: 1680-1684.
15. Molinari A, Giorgetti C, Lansen J, Vaghi F, Orsini G, Faioni EM, et al. Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model. Thromb Haemost 1992; 67: 226-232.
16. Wilhelm S, Wilhelm O, Schmitt M, Graeff H. Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/ thrombomodulin complex. Biol Chem Hoppe-Seyler 1994; 375: 603-608.
17. Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990; 75: 329-336.
18. Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982; 257: 7944-7947.
19. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746.
20. Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996; 271: 16603-16608.
21. Sakharov DV, Plow EF, Rijken DC. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem 1997; 272: 14477-14482.
22. Dooijewaard G, Van Iersel JJL, Brommer EJP. Quantitation of pro-UK, UK and UK inhibitor levels in plasma of patients and healthy men. In: Binder BR (editor). Fibrinolysis (8th International Congress on Fibrinolysis). Edinburgh: Churchill Livingstone, 1986; Abstr. 142.
23. Binnema DJ, Dooijewaard G, Turion PNC. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein. Thromb Haemost 1991; 65: 144-148.
24. 2-macroglobulins, serpins and kunins. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (editors). Hemostasis and thrombosis. Philadelphia: J.B. Lippincott Company; 1994. pp. 241-258.
25. Béguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost 1989; 61: 25-29.
26. Hofsteenge J, Taguchi H, Stone SR. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem J 1986; 237: 243-251.
27. Jakubowski HV, Kline MD, Owen WG. The effect of bovine thrombomodulin on the specificity of bovine thrombin. J Biol Chem 1986; 261: 3876-3882.
28. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-14484.
29. Carmeliet P, Collen D. Targeted gene manipulation and transfer of the plasminogen and coagulation system in mice. Fibrinolysis 1996; 10: 195-213.
30. Von dem Borne PAK, Koppelman SJ, Bouma BN, Meijers JCM. Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen. Thromb Haemost 1994; 72: 397-402.
31. Bertina RM, Van Tilburg NH, De Fouw NJ, Haverkate F. Thrombin, a link between coagulation activation and fibrinolysis. Ann N Y Acad Sci 1992; 667: 239-248.
32. Bajzar L, Nesheim M. The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation. J Biol Chem 1993; 268: 8608-8616.
33. Bajzar L, Nesheim ME, Tracy PB. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood 1996; 88: 2093-2100.
34. Leiden. J Biol Chem 1996; 271: 22949-22952.
35. Heijboer H, Brandjes DPM, Büller HR, Sturk A, Ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-1516.
36. Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic disease-critical evaluation of laboratory investigation. Thromb Haemost 1992; 68: 7-13.
37. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-662.
38. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 824-834.